BIOMEDICAL CATALYST FUND

Biomedical Catalyst Fund invests in the pre-clinical development and early clinical testing of novel therapeutics.

#Financial #More

BIOMEDICAL CATALYST FUND

Industry:
Biotechnology

Status:
Active


Investments List

Date Company Article Money raised
2022-08-24 Gripable Biomedical Catalyst Fund investment in Grant - Gripable 800 K GBP
2022-03-30 Invizius Biomedical Catalyst Fund investment in Grant - Invizius 1000 K GBP
2021-02-18 Vinehealth Biomedical Catalyst Fund investment in Grant - Vinehealth 1000 K GBP
2019-07-10 SleepCogni Biomedical Catalyst Fund investment in Grant - SleepCogni 234 K GBP
2019-01-30 MediSieve Biomedical Catalyst Fund investment in Grant - MediSieve 1.56 M GBP
2014-05-01 Calcivis Biomedical Catalyst Fund investment in Grant - Calcivis 1.3 M GBP
2014-03-26 Adaptimmune Biomedical Catalyst Fund investment in Grant - Adaptimmune 3.5 M USD
2013-07-31 Summit Therapeutics Biomedical Catalyst Fund investment in Grant - Summit Therapeutics 2.4 M GBP
2013-05-30 Atopix Therapeutics Biomedical Catalyst Fund investment in Grant - Atopix Therapeutics 1.7 M USD
2012-11-06 Arecor Biomedical Catalyst Fund investment in Grant - Arecor 785 K GBP

More informations about "Biomedical Catalyst Fund"

Biomedical Catalyst โ€“ UKRI - UK Research and Innovation

Aug 17, 2023 The Biomedical Catalyst supports small and medium-sized businesses, of all stages, to: ... bring in private capital alongside grants for projects; Biomedical Catalyst will fund a variety of projects across different markets, technologies, strands and themes, including: โ€ฆSee details»

Biomedical Catalyst Fund - Crunchbase

Biomedical Catalyst Fund may be growing as evidenced by the recent award of a £405K Innovate UK Biomedical Catalyst Grant to SolasCure, which is indicative of active investment in the โ€ฆSee details»

Biomedical Catalyst 2024 Round 1: Industry-led R&D

Sep 2, 2024 The Biomedical Catalyst (BMC) was established in 2012 and identified a market failure in terms of access to funding for early-stage UK life sciences companies. Life Sciences โ€ฆSee details»

Biomedical catalyst 2024 round one: industry-led R&D โ€“ UKRI

Sep 2, 2024 See the full opportunity details on the Innovation Funding Service. UK registered SMEs can apply for a share of up to £15 million to develop innovative solutions to health, and โ€ฆSee details»

Innovate UK - Biomedical Catalyst - Innovate UK โ€ฆ

Biomedical Catalyst is technology agnostic; we want to fund a variety of projects across different markets, technologies, strands and themes. How it works By awarding grants to UK-based businesses of varying stages of development, โ€ฆSee details»

Biomedical Catalyst | BIA - bioindustry.org

The BIA has been the driving force in making a compelling case for the interests of UK life science SMEs in Whitehall and Westminster. Your campaign to re-fund the Biomedical Catalyst, with โ€ฆSee details»

Biomedical Catalyst 2023 Round 1: Industry-led R&D

Jan 4, 2023 The Biomedical Catalyst (BMC) was established in 2012 and identified a market failure in terms of access to funding for early-stage UK life sciences companies. Life Sciences โ€ฆSee details»

Catalyst Grant: Development and Validation of New Biomedical โ€ฆ

Development and validation of new biomedical technologies is a high-risk high-reward endeavour. There is, and clearly will be, an ongoing and ever-increasing demand for new technologies โ€ฆSee details»

Take on the biggest healthcare challenges: apply for โ€ฆ

Jan 17, 2019 Biomedical Catalyst funding supported the evaluation of performance and safety data. It has helped to move the device one step closer to being used on patients in clinical trials โ€“ with the ...See details»

Biomedical Catalyst 2024 Round One: Industry-Led R&D

Oct 9, 2024 The Biomedical Catalyst 2024 Round One: Industry-Led R&D funding opportunity is open to UK registered SMEs seeking funding to develop innovative solutions for health and โ€ฆSee details»

Biomedical Catalyst Funding Programe in the UK - fundsforNGOs

Deadline: 25-May-22 Innovate UK, part of UK Research and Innovation has announced Biomedical Catalyst funding programme to support UK businesses to test and develop โ€ฆSee details»

The Biomedical Catalyst: an evaluation report โ€“ UKRI

Mar 21, 2017 the Biomedical Catalyst should seek to increase outreach to the medtech community and emerging sectors such as digital health; Future evaluation of the Biomedical โ€ฆSee details»

Biomedical Catalyst 2021 Round 2: Feasibility & Primer Awards

Oct 18, 2021 The Biomedical Catalyst (BMC) was established in 2012, and identified a market failure in terms of access to funding for early stage UK life sciences companies. Life Sciences โ€ฆSee details»

Biomedical Catalyst 2022 Round 2: Industry-led R&D

Aug 15, 2022 The Biomedical Catalyst (BMC) was established in 2012, and identified a market failure in terms of access to funding for early stage UK life sciences companies. Life Sciences โ€ฆSee details»

Biomedical Catalyst Fund - Investments, Portfolio & Company Exits

Dec 16, 2022 Biomedical Catalyst Fund 's most notable exits include Immunocore, Adaptimmune, and Summit Therapeutics. Which industries has this organization had the most โ€ฆSee details»

List of Biomedical Catalyst Fund's 15 Investments ... - Crunchbase

List of Biomedical Catalyst Fund 's 15 Investments, including Alchemab Therapeutics and Gripable. Save Search . Companies . Contacts . Investors ...See details»

Biomedical Catalyst Fund - Crunchbase

Companies like Biomedical Catalyst Fund include Merck, Xvir Therapeutics, and R&D Biopharmaceuticals. Merck Darmstadt , Hessen , Germany 539 Contacts 10001+ employeesSee details»

Federal Budget Recognizes Strategic Importance of Canadaโ€™s โ€ฆ

Apr 19, 2021 $50 million on a cash basis over five years, starting in 2021-22, to create a life sciences stream in the Venture Capital Catalyst Initiative, as part of a larger venture capital โ€ฆSee details»

Biomedical catalyst 2021: early and late stage awards

Jun 7, 2021 The Biomedical Catalyst (BMC) was established in 2012, and identified a market failure in terms of access to funding for early stage UK life sciences companies. Life Sciences โ€ฆSee details»

Biomedical Catalyst Fund - raizer.app

Biomedical Catalyst Fund invests in the pre-clinical development and early clinical testing of novel therapeutics. Learn which startups Biomedical Catalyst Fund invests in, number of โ€ฆSee details»